Isolation and Characterization of Antibacterial Metabolites Produced by Streptomyces species from Escravos River, Delta State, Nigeria https://doi.org/10.26538/tjnpr/v1i1.5
Main Article Content
Abstract
The isolation of Streptomyces sp that yields bioactive molecule is of significant importance in the advancement of new metabolite to combat pathogen. Water, soil and sediment samples were obtained from Escravos River, Delta State. The analysis was carried out using standard culturebased method and polymerase chain reaction approach for identification of the isolates. Of the thirty-six putative Streptomyces sp screened using ethyl acetate crude extracts, five showed varying levels of antimicrobial activities against test bacterial isolates used. This five putative Streptomyces were further identified by partial sequencing the 16S rDNA amplified polymerase chain reaction (PCR) products. The BLAST analysis revealed 99-100% Streptomycessp similarity in the GenBank nucleotide database. The five Streptomyces sp were ESC003 (Streptomyces griseus), ESC012 (Streptomyces griseus), ESC021 (Streptomyces sp.), ESC022 (Streptomyces fulvissimus) and ESC030 (Streptomyces sp.). Physiological conditions for optimum biomassyields were found to be pH 7 temperature at 28°C incubation days (7-10) and specific rate of metabolite production at day 6 (0.004-0.0045 day-1 ) from the 5 Streptomyces sp characterized.The MIC values unveiled by all the extracts ranged from 0.016 to 0.056 mg/mL. The minimum bactericidal concentration (MBC) of the extracts ranged between 2.5 and >10 mg/mL. On the time kill assay, the utmost reductions in cell population’s density were revealed by ESC021 and ESC030 against Staphylococcus aureus ATCC 25823. Findings from this study revealed that extracts of the Streptomyces isolates from Escravos River have antimicrobial properties with the potential for novel drugs discoveries.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Olano C, Mendaz C and Salar JA. Antitumour compounds from marine actinomycetes. Marine Drugs 2009; 7: 210-248.
Ogunmwonyi IH, Mazomba N, Mabinya L, Ngwenya E, Green E, Akinpelu DA, Olaniran AO, Bernard K and Okoh AI. Studies on
the culturable marine actinomycetes isolated from the Nahoon beach in the Eastern Cape Province of South Africa. Afr J Microbiol Res 2010a;
: 2223 – 2230.
Singh SB & Pelaez F (2010). Terrestrial microorganisms: Filamentous bacteria. In: Comprehensive Natural Products II (pp. 109-140). Mander, L. and Liu, H.-W., Eds., Elsevier, Amsterdam.
Ambavane V, Tokdar P, Parab R, Sreekumar ES, Mahajan G, Mishra PD, D’Souza L and Ranadive P. Caerulomycin A-an antifungal compound isolated from marine actinomycetes. Adv Microbiol 2014; 4: 567-578.
Gebreselema G, Feleke M and Samuel S. Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of Lake Tana, Ethiopia. Asian Pacific J Trop Biomed 2013; 3: 426-435.
Sweetline C, Usha R and Palaniswamy M. Antibacterial activity of actinomycetes from Pichavaram Mangrove of Tamil Nadu. Appl J Hyg 2012; 1: 15-18.
Kumar SP, Raj PPJ, Duraipandiyan V and Ignacimuthu S. Antibacterial activity of some actinomycetes from Tamil Nadu, India. Asian Pacific J Trop Biomed 2012; 2: 936-943.
Manivasagan P, Venkatesan J, Sivakumar K and Kim SK. Marine actinobacterial metabolites: Current status and future perspectives. Microbiol Res 2013; 168: 311-332.
Balagurunathan R, Masilamani M and Kathiresan SK. Bioprospecting of mangrove rhizosphere actinomycetes from Pitchavaram with special reference to antibacterial activity. J Pharm 2010; 3: 909-911.
Ogunmwonyi IH, Mazomba N, Mabinya L, Ngwenya E, Green E, Akinpelu DA, Olaniran AO and Okoh AI. In vitro time-kill studies of antibacterial agents from putative marine Streptomyces species isolated from the Nahoon beach, South Africa. Afr J Pharm Pharmacol 2010b; 4: 908-916.
Cwala Z, Igbinosa EO and Okoh AI. Assessment of antibiotics production potentials in four actinomycetes isolated from aquatic environments of the Eastern Cape Province of South Africa. Afr J Pharm Pharmacol 2011; 5: 118-124.
Wanq L, Yun BS, Geirge NP, Wendt-Pienkowski E, Galm U, Oh TJ, Couqhlin JM, Zhang G, Tao M and Shen B. Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: Strain improvement and structure elucidation. J Nat Prod 2007; 70: 402–406.
Hopwood DA, Buttner MJ, Kieser T and Charter KF. Antibiotic production by Streptomyces. Pract Streptomyces Genet 2000; 1: 1-42.
Balagurunathan, R., Radha, R., & Krishnan, M. (2007). Actinomyces diversity and their importance in microbiology applications and current trends. P.C. Trivedi (Editor) (pp. 297-329). Pointer Publishers, Jaipur, India.
Zin NM, Sarmin NIM, Ghadin N, Basri DF, Sidik NM, Hess WM and Strobel GA. Bioactive endophytic streptomycetes from the Malay Peninsula. FEMS Microbiol Lett 2007; 274: 83–88.
Singh SL, Sharma H and Talukdar CN. Production of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from Phoomdi in Loktak Lake of Manipur, India. BMC Microbiol 2014; 14: 278-291.
Ekwenye UN and Kazi E. Investigation of plasmid DNA and antibiotic resistance in some pathogenic organism. Afr J Biotechnol 2007; 6: 877-880.
Zotchev SB. Marine actinomycetes as an emerging resource for the drug development pipelines. J Biotechnol 2011; 158: 168-175.
Talbot GH, Bradely J, Edwards JE, Gilbert D, Scheld M and Bartlett JG. Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the Infectious Disease Society of America. Clin Infect Dis 2006; 42: 657-668.
Mohseni M, Norouzi H, Hamedi J and Roohi A. Screening of antibacterial producing actinomycetes from sediments of the Caspian Sea. Int J Mol Cell Med 2013; 2: 64-72.
Baskaran R, Vijayakumar R and Mohan PM. Enrichment method for the isolation of bioactive actinomycetes from mangrove sediments of Andaman Islands, India. Malay J Microbiol 2011; 7: 26-32.
Saadoun I and Gharaibeh R. The Streptomyces flora of Badia region of Jordan and its potential as a source of antibioticresistant bacteria. J Arid Environ 2003; 53: 365-371.
Nedialkova D and Naidenova M. Screening the antimicrobial activity of actinomycetes strains isolated from Antarctica. J Culture Collect 2005; 4: 29–35.
Singh LS, Mazumder S and Bora TC. Optimisation of process parameters for growth and bioactive metabolite produced by a salt-tolerant and alkaliphilic, Streptomyces tanashiensis strain A2D. J Mycol Med 2009; 19: 225–233.
Ghanem NB, Sanry SA, El-Sherif ZM, El-Ela GAA. Isolation and enumeration and marine actinomycetes from seawater and sediments in Alexandria. J Genet Appl Microbiol 2000; 46: 105-111.
Cheesbrough M (2005). District Laboratory Practice in Tropical Countries (pp. 30-41). Cambridge University Press, United Kingdom.
Donay JL, Fernandes P, Lagrange PH and Herrmann JL. Evaluation of the inoculation procedure using a 0.25 McFarland Standard for the BD Phoenix Automated Microbiology System. J Clin Microbiol 2007; 45: 4088-4089.
Forbes, B. A., Sahm, D. F., Weissfeld, A. S. & Trevino, E. A. (1990) Bailey and Scott’s Diagnostic Microbiology (pp. 171 –194). St. Louis, Missouri: Mosby Co.
Igbinosa EO and Idemudia OG. Anti-vibrio potentials of acetone and aqueous leaf extracts of Ocimum gratissimum(Linn). Trop J Pharm Res 2016; 15: 743-750.
LeDuy A and Zajic JE. A geometrical approach for differentiation of an experimental function at a point: Applied to growth and product formation. Biotechnol Bioeng 1973; 15: 805-810.
Rintala H, Nevalainen A and Suutari M. Diversity of Streptomyces in water-damaged building materials based on 16S rDNA sequences. Let Appl Microbiol 2002; 34: 439-443.
Pernodet JL, Boccard F, Alegre MT, Gagmat J and Guerineau M. Organisation and nucleotide sequence analysis of a ribosomal RNA cluster from Streptomyces ambofaciens. Gene 1989; 79: 33–46
Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.
Ilic SB, Konstantinovic SS, Todorovic ZB, Lazic ML, Veljkovic VB, Jokovic N and Radovanovic BC. Characterization and antimicrobial activity of the bioactive metabolites in Streptomycete isolates. Microbiol 2007; 76: 421–428.
Ellof JN. A sensitive and quick micro plate method to determine the minimal inhibitory concentration of plant extract for bacteria. Plant Medica 1998; 64: 711-713.
Spangler SK, Jacobs MR and Appelbaum PC. Bactericidal activity of DU-6859 as compared to activities of three quinolones, three β-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology. Antimicrob Agents Chemoth 1997; 41: 847-849.
Demain AL. Prescription for an ailing pharmaceutical industry. Nat Biotechnol 2002; 20: 331-339.
Sabaou N, Boudjella H, Bennadji A, Mostefaoui A, Zitouni A, Lamari L, Bennadji H, Lefebvre G and Germain P. Les sols des oasis du Sahara alge´rien, source d’actinomyce`tes rares producteurs d’antibiotiques. Se´cheresse 1998; 9: 147–153.
Barakate M, Ouhdouch Y, Oufdou K and Beaulieu C. Characterization of rhizospheric soil Streptomycetes from Moroccan habitats and their antimicrobial activities. World J Microbiol Biotechnol 2002; 18: 49–54.
Ilić SB, Konstantinović SS and Todorović ZB. Uv/vis analysis and antimicrobial activity of Streptomyces isolates. Facta Universitatis Series: Med Biol 2005; 12: 44 – 46.
Oskay M, Tamer A and Azeri C. Antibacterial activity of some actinomycetes isolated from farming soils of Turkey. Afr J Biotechnol 2004; 3: 441–446.
Mohan J, Sirisha B, Haritha R and Ramana T. Selective screening, isolation and characterization of antimicrobial agents from marine actinomycetes. Int J Pharm Sci 2013; 5: 443-449.
Peela S, Kurada B and Terli R. Studies on antagonistic marine actinomycetes from the Bay of Bengal Department of Biotechnology, College of Science and Technology, Andhra University, Visakhapatnam, India. Microbiol 2004; 73: 221–228.
Remya M and Vijayakumar R. Isolation and characterization of marine antagonistic actinomycetes from West Coast of India. Facta Universitatis Series: Med Biol 2008; 15: 13-19.
Zgurskaya HI and Nikaido H. Multidrug resistance mechanisms: Drug efflux across two membrane. Mol Microbiol 2000; 37: 219-225.
Zarina A and Nanda A. Antimicrobial, antioxidant and cytotoxic activity of marine Streptomyces MS-60 isolated from Bay of Bengal. Int J Sci Res 2012; 3: 1634-1641.
Igbinosa EO, Beshiru A, Akporehe LU and Ogofure AG. Detection of methicillin-resistant staphylococci isolated from food producing animals: A public health implication. Vet Sci 2016a; 3: 1-11.
Igbinosa EO, Beshiru A, Akporehe LU, Oviasogie FE and Igbinosa OO. Prevalence of methicillin-resistant Staphylococcus aureus and other Staphylococcus species in raw meat samples intended for human consumption in Benin City, Nigeria: Implications for public health. Int J Environ Res Pub Health 2016b; 13: 949-960.
Song Q, Huang Y, Yang H. Optimization of fermentation conditions for antibiotic production by Actinomycetes YJ1 strain against Sclerotinia sclerotiorum. J Agr Sci 2012; 4: 95-103.
Abussaud MJ, Alanagreh L and Abu-Elteen K. Isolation, characterization and antimicrobial activity of Streptomyces strains from hot spring areas in the Northern part of Jordan. Afr J Biotechnol 2013; 12: 7124-7132.
El-Gendy MAA, Shaaban M, EL-Bondkly AM and Shaaban KA. Bioactive benzopyrone derivatives from new recombinant fusant of marine Streptomyces. Appl Biochem Biotechnol2008; 150: 85–96.
Atta HM, Dabour SM and Desoukey SG. Sparsomycin antibiotic production by Streptomyces sp. AZ-NIOFD1: taxonomy, fermentation, purification and biological activities. Am Eur J Agr Environ Sci 2009; 5: 368-377.
Pandey B, Ghimire P and Agrawal VP. Studies on the antibacterial activity of actinomycetes isolated from the Khumbu region of Mt. Everest. A paper presented in the International Conference on the Great Himalayas: Climate, Health, Ecology, Management and Conservation, Kathmandu. January 12-15. Organized by Kathmandu University and the Aquatic Ecosystem Health and Management Society, Canada. Clin Microbiol Rev 2004; 1: 432-444.
Isnansetyo A and Kamei Y. MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemoth 2003; 47: 480–488.
Watanakunakorn C and Tisone J. Synergism between Nformimidoyl thienamycin and gentamicin or tobramycin against enterococci. Antimicrob Agents Chemoth 1982; 22: 1082-1083
Parajuli NP, Joshi G, Pardhe BD, Shakya I, Bhetwal A, Shakya S, Pandit R, Shrestha SS and Khana PR. Shigellosis caused by ctx-m type ESBL producing Shigella flexneri in two siblings of rural Nepal: First case report from the country. Case Reports Infect Dis 2017; 5 pages doi.org/10.1155/2017/1862320.
Baker KS, Dallman TJ, Field N, Childs T, Were J, Hughes G, Jenkins C and Thomson NR. Common determinants of antimicrobial resistance in sequential episodes of sexually transmitted shigellosis in men who have sex with men: A crosssectional study. The Lancet 2017; 389.
Bakhshi B, Bayat B and Lari AR. Multiple- locus variablenumber tandem-repeat analysis (MLVA) of Shigella sonnei isolates of 2012 outbreak I. R. Iran. Microbial Pathog 2017; 102: 69–73.
Gu B, Qina T, Fana W, Bia R, Chena Y, Lia Y and Ma Y. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002-2011. Int J Infect Dis 2017; In Press, doi.org/10.1016/j.ijid.2017.03.023
Murray K, Reddy V, Kornblum JS, Waechter H, Chicaiza LF, Rubinstein I, Balter S, Greene SK, Braunstein SL, Rakeman JL and Dentinger CM. Increasing antibiotic resistance in Shigellaspp. from infected New York city residents, New York, USA. Emerg Infect Dis 2017; 23(2): 332–335.
Ren L, Deng L, Zhang R, Wang C, Li D, Xi L, Chen Z, Yang R, Huang J, Zeng Y, Wu H, Cao S, Wu R, Huang Y and Yan Q. Relationship between drug resistance and the clustered, regularly interspaced, short, palindromic repeat-associated protein genes cas1 and cas2 in Shigella from giant panda dung. Med 2017; 96(7): e5922.
Shen H, Chen J, Xu Y, Lai Z, Zhang J, Yang H, Li Y, Jiang M, Ye Y and Bai X. An outbreak of shigellosis in a Children Welfare Institute caused by a multiple-antibiotic-resistant strain of Shigella flexneri 2a. J Infect Pub Health 2017; In Press, http://doi.org/10.1016/j.jiph.2017.01.003
Shimanovich AA, Buskirk AD, Heine SJ, Blackwelder WC, Wahid R, Kotloff KL and Pasetti MF. Functional and antigenspecific serum antibody levels as correlates of protection against shigellosis in a controlled human challenge study. Clin Vaccine Immunol 2017; 24 (2): 412-416.
Leupold S, Büsinga P, Masb PJ, Hartb DJ and Scrima A. Structural insights into the architecture of the Shigella flexnerivirulence factor IcsA/VirG and motifs involved in polar distribution and secretion. J Struct Biol 2017; In Press, doi.org/10.1016/j.jsb.2017.03.003
Chattaway MA, Schaefer U, Tewolde R, Dallman TJ and Jenkins C. Identification of Escherichia coli and Shigellaspecies from whole-genome sequences. J Clin Microbiol 2017; 55(2): 616-623.